Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Should California buy out doomed beach homes threatened by rising seas?

    noviembre 22, 2026

    Three killed and dozens missing after fire at Indonesian factory

    noviembre 22, 2026

    What China Gets From Its AI Honeypots and Smuggled Chips

    noviembre 22, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Should California buy out doomed beach homes threatened by rising seas?
    • Three killed and dozens missing after fire at Indonesian factory
    • What China Gets From Its AI Honeypots and Smuggled Chips
    • Star Trek Turned These Classic Movies Into Something Very Different
    • Bowl projections: Slotting all 47 games as Week 12 upsets provide massive shakeup to postseason picture
    • Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more
    • Former Uber driver ‘who hated the rich’ guilty of starting deadly LA fire
    • JD Vance Should Not Be Finger-Pointing in the Midst of War
    Facebook X (Twitter) Instagram
    Al Punto Hoy
    • National News
    • International News
    • Politics
    • Economy
    • Health
    • Entertainment
    • Sports
    Al Punto Hoy
    Portada » ASCO News: Bristol and Pfizer report favorable results — Day 1
    Health

    ASCO News: Bristol and Pfizer report favorable results — Day 1

    Al Punto Hoy from ANASTACIO ALEGRIABy Al Punto Hoy from ANASTACIO ALEGRIAmayo 30, 2026No hay comentarios3 Views
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    ASCO News: Bristol and Pfizer report favorable results — Day 1
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Chicago, where thousands in the cancer world gather each year.Adam Feuerstein/STAT

    Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

    Matthew Herper covers medical innovation — both its promise and its perils.

    Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You can reach Angus on Signal at angus.08.

    You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.  

    We’re ASCOmaxxing.

    Rest assured, this will not require Adam Feuerstein, Matthew Herper or Angus Chen to hammer on their jawlines. They will, however, be scouring the ASCO annual meeting to bring you the cancer news, analysis and event coverage you crave.

    STAT+ Exclusive Story

    Already have an account? Log in

    Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more



    STAT+

    This article is exclusive to STAT+ subscribers

    Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

    Already have an account? Log in

    View All Plans

    To read the rest of this story subscribe to STAT+.

    Subscribe

    1. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

    2. Senior Writer, Medicine, Editorial Director of Events

      Matthew Herper covers medical innovation — both its promise and its perils.

    3. Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You can reach Angus on Signal at angus.08.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Al Punto Hoy from ANASTACIO ALEGRIA
    • Website

    Related Posts

    Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more

    noviembre 22, 2026

    Moderate Coffee Drinking Tied to Lower Stroke Risk, With Estimated Risk Lowest Near 2.6 Cups a Day

    noviembre 21, 2026

    Radiologists link small abdominal muscles to lower back pain

    noviembre 20, 2026
    Leave A Reply Cancel Reply

    Top Posts

    Pharmalittle: Trump getting more credit than Biden on drug prices

    marzo 13, 2026476

    Birthright Citizenship Case at Supreme Court Affects All Americans

    abril 1, 2026440

    Nearly locked into play-in, Warriors try to improve seeding vs. Wizards

    marzo 27, 2026378

    Links 3/30/2026 | naked capitalism

    marzo 30, 2026362
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo

    Subscribe to Updates

    Get the latest news from alpuntohoy.

    About Us
    About Us

    Welcome to AlPuntoHoy, your trusted source for timely, accurate, and engaging news from around the world. Our mission is to keep readers informed with reliable reporting, insightful analysis, and comprehensive coverage across a wide range of topics.

    WhatsApp
    Most Popular

    Pharmalittle: Trump getting more credit than Biden on drug prices

    marzo 13, 2026476

    Birthright Citizenship Case at Supreme Court Affects All Americans

    abril 1, 2026440

    Nearly locked into play-in, Warriors try to improve seeding vs. Wizards

    marzo 27, 2026378
    Categorías
    • Economy
    • Entertainment
    • Health
    • International News
    • National News
    • Politics
    • Sports
    • Uncategorized
    © 2026 All rights reserved AlPuntoHoy.
    • Home
    • About Us
    • Contact Us
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.